To continue to meet and exceed customer expectations in our developing commercial markets, QIAGEN plans to optimize and diversify its technology interests in the following areas:
- Novel technologies for handling and preparing samples prior to analysis of nucleic acids and proteins
- Fractionation, enrichment, and depletion technologies
- Amplification technologies
- Storage, retrieval, and transportation solutions
- Molecular testing, clinical research, and diagnostics using nucleic acids
- RNAi synthesis, design, modification, and delivery
- Gene expression at the RNA and protein level
- General molecular biology research
For information on co-developing a companion diagnostic with us, see our Companion Diagnostic Partnership page.
Business and technology development
If you know of any product/service development opportunities in the above fields, we would be very interested in hearing from you. Please contact:
Email: bd@qiagen.com